Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.46
-0.05 (-0.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | -197.53 | -235.76 | -151.09 | -216.21 | -381.9 | Upgrade
|
| Depreciation & Amortization | 0.32 | 0.34 | 0.31 | 0.13 | 0.03 | Upgrade
|
| Other Amortization | 1.76 | 0.6 | 0.5 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 220.45 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.8 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 30.96 | 33.55 | 29.39 | 24.97 | 14.85 | Upgrade
|
| Other Operating Activities | 2.51 | 37.05 | -20.63 | -6.78 | 16.43 | Upgrade
|
| Change in Accounts Payable | 0.05 | -4.59 | -2.72 | 6.35 | 3.8 | Upgrade
|
| Change in Other Net Operating Assets | -30.08 | 26.75 | -16.11 | -9.01 | -9.83 | Upgrade
|
| Operating Cash Flow | -193.82 | -142.06 | -160.34 | -200.55 | -136.16 | Upgrade
|
| Capital Expenditures | -0.37 | -0.03 | -0.17 | -1.14 | -0.19 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 63.44 | Upgrade
|
| Investment in Securities | -418.16 | 31.3 | -126.84 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | 0.21 | - | Upgrade
|
| Investing Cash Flow | -418.53 | 31.27 | -127 | -0.93 | 63.26 | Upgrade
|
| Long-Term Debt Issued | - | 109.34 | - | - | 73.93 | Upgrade
|
| Long-Term Debt Repaid | - | -110.1 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.76 | - | - | 73.93 | Upgrade
|
| Issuance of Common Stock | 296.72 | 370.83 | 21.12 | 0.72 | 344.92 | Upgrade
|
| Repurchase of Common Stock | -4.79 | -5.32 | - | - | - | Upgrade
|
| Other Financing Activities | -0.4 | - | - | -0.26 | -0.3 | Upgrade
|
| Financing Cash Flow | 291.53 | 364.75 | 21.12 | 0.46 | 660.15 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.45 | 1.23 | 0.62 | -0.42 | 1.9 | Upgrade
|
| Net Cash Flow | -321.27 | 255.19 | -265.61 | -201.44 | 589.15 | Upgrade
|
| Free Cash Flow | -194.19 | -142.09 | -160.51 | -201.68 | -136.34 | Upgrade
|
| Free Cash Flow Margin | -1294.59% | - | -2342.20% | - | - | Upgrade
|
| Free Cash Flow Per Share | -1.43 | -1.24 | -1.67 | -2.16 | -1.81 | Upgrade
|
| Cash Interest Paid | 9.46 | 10.09 | 9.91 | 7.28 | 1.48 | Upgrade
|
| Cash Income Tax Paid | 1.33 | 0.08 | 2.94 | 1.3 | - | Upgrade
|
| Levered Free Cash Flow | -138.54 | -75.19 | -96.6 | -108.73 | -82.08 | Upgrade
|
| Unlevered Free Cash Flow | -132.53 | -68.88 | -90.41 | -104.18 | -80.49 | Upgrade
|
| Change in Working Capital | -30.03 | 22.16 | -18.83 | -2.66 | -6.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.